Transmedics
TMDX
200 hedge funds and large institutions have $1.77B invested in Transmedics in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 11 closing their positions.
227% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 11
151% more call options, than puts
Call options by funds: $19.5M | Put options by funds: $7.77M
125% more funds holding in top 10
Funds holding in top 10: 4 → 9 (+5)
50% more capital invested
Capital invested by funds: $1.18B → $1.77B (+$592M)
17% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 66
12% more funds holding
Funds holding: 179 → 200 (+21)
0.33% more ownership
Funds ownership: 90.48% → 90.81% (+0.33%)
Top Buyers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$22.1M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$20.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$15.8M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$14.2M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$11.6M |
Top Sellers
TMDX Hedge Fund Activity: Q4 2022 in Review
200 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2022, worth a combined $1.77B — up 50% from $1.18B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new TMDX positions and 11 closed out — a net gain of 25 holders — while 77 added to existing stakes and 66 trimmed.
The largest buyer was Lord, Abbett & Co, adding an estimated $22.1M. The largest seller was Fidelity Investments, cutting an estimated $35.3M.
- 200 institutional investors held Transmedics (TMDX) as of Q4 2022, up from 179 in Q3 2022.
- Funds reported $1.77B of Transmedics stock for Q4 2022, up 50% quarter-over-quarter.
- 36 funds opened new Transmedics positions in Q4 2022 and 11 closed out, a net change of +25 holders.
- The largest Transmedics buyer in Q4 2022 was Lord, Abbett & Co, an estimated $22.1M added.
- The largest Transmedics seller in Q4 2022 was Fidelity Investments, an estimated $35.3M sold.
Based on aggregated 13F filings for Q4 2022.